Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps

ABSTRACT Background. Dose painting by numbers (DPBN) is a method to deliver an inhomogeneous tumor dose voxel-by-voxel with a prescription based on biological medical images. However, planning of DPBN is not supported by commercial treatment planning systems (TPS) today. Here, a straightforward method for DPBN with a standard TPS is presented. Material and methods. DPBN tumor dose prescription maps were generated from 18F-FDG-PET images applying a linear relationship between image voxel value and dose. An inverted DPBN prescription map was created and imported into a standard TPS where it was defined as a mock pre-treated dose. Using inverse optimization for the summed dose, a planned DPBN dose distribution was created. The procedure was tested in standard TPS for three different tumor cases; cervix, lung and head and neck. The treatment plans were compared to the prescribed DPBN dose distribution by three-dimensional (3D) gamma analysis and quality factors (QFs). Delivery of the DPBN plans was assessed with portal dosimetry (PD). Results. Maximum tumor doses of 149%, 140% and 151% relative to the minimum tumor dose were prescribed for the cervix, lung and head and neck case, respectively. DPBN distributions were well achieved within the tumor whilst normal tissue doses were within constraints. Generally, high gamma pass rates (> 89% at 2%/2 mm) and low QFs (< 2.6%) were found. PD showed that all DPBN plans could be successfully delivered. Conclusions. The presented methodology enables the use of currently available TPSs for DPBN planning and delivery and may therefore pave the way for clinical implementation.

[1]  V. Grégoire,et al.  Generation of prescriptions robust against geometric uncertainties in dose painting by numbers , 2015, Acta oncologica.

[2]  Xindong Sun,et al.  PET/CT imaging-guided dose painting in radiation therapy. , 2014, Cancer letters.

[3]  Wouter van Elmpt,et al.  Impact of PET reconstruction algorithm and threshold on dose painting of non-small cell lung cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  S. Korreman,et al.  Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Andre Dekker,et al.  Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer , 2013, Acta oncologica.

[6]  T. Vercauteren,et al.  Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Jan-Jakob Sonke,et al.  Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer , 2013, BMC Cancer.

[8]  Marcel van Herk,et al.  Dealing with geometric uncertainties in dose painting by numbers: introducing the ΔVH. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  M. Bal,et al.  Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  Fréderic Duprez,et al.  Adaptive dose painting by numbers for head-and-neck cancer. , 2011, International journal of radiation oncology, biology, physics.

[11]  Vincent Gregoire,et al.  Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.

[12]  R. Jeraj,et al.  Feasibility of dose painting using volumetric modulated arc optimization and delivery , 2010, Acta oncologica.

[13]  E. Malinen,et al.  Influence of MLC leaf width on biologically adapted IMRT plans , 2010, Acta oncologica.

[14]  R. Jeraj,et al.  Feasibility and sensitivity study of helical tomotherapy for dose painting plans , 2010, Acta oncologica.

[15]  Daniela Thorwarth,et al.  Physical radiotherapy treatment planning based on functional PET/CT data. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  P. Lambin,et al.  Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Randall K Ten Haken,et al.  Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. , 2009, International journal of radiation oncology, biology, physics.

[18]  Dag Rune Olsen,et al.  Strategies for biologic image-guided dose escalation: a review. , 2009, International journal of radiation oncology, biology, physics.

[19]  P. Grigsby The prognostic value of PET and PET/CT in cervical cancer , 2008, Cancer imaging : the official publication of the International Cancer Imaging Society.

[20]  Daniela Thorwarth,et al.  Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.

[21]  H. Thierens,et al.  Implementation of biologically conformal radiation therapy (BCRT) in an algorithmic segmentation-based inverse planning approach , 2006, Physics in medicine and biology.

[22]  H. Thierens,et al.  [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  Joos V Lebesque,et al.  Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. , 2005, European journal of cancer.

[24]  Søren M Bentzen,et al.  Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.

[25]  Mohamed Allaoua,et al.  Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. , 2004, International journal of radiation oncology, biology, physics.

[26]  M Alber,et al.  On biologically conformal boost dose optimization. , 2003, Physics in medicine and biology.

[27]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.